Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.219
Neutral
RSI(14)
50.063
Neutral
STOCH(KDJ)(9,3,3)
26.010
Sell
ATR(14)
0.530
Low Volatility
CCI(14)
-142.283
Sell
Williams %R
83.704
Oversold
TRIX(12,20)
0.869
Sell
StochRSI(14)
0.000
Oversold
electroCore, Inc.
ECORView Detailed Chart
6.770USD
-0.150-2.17%
Close 08/01, 16:00（ET）Quotes delayed by 15 min
50.24MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-2.17%
5 Days
-12.65%
1 Month
+10.80%
6 Months
-57.98%
Year to Date
-58.24%
1 Year
+14.55%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
5
analysts
BUY
Current Rating
20.880
Target Price
208.42%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
8
Average
Company name
Ratings
Analysts
electroCore, Inc.
ECOR
5
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
28
1
2
3
...
24
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Sell
Moving Average
Indicators
Value
Direction
MA5
6.960
Sell
MA10
7.148
Sell
MA20
7.177
Sell
MA50
6.032
Buy
MA100
6.411
Buy
MA200
10.218
Sell
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.
Ticker SymbolECOR
CompanyelectroCore, Inc.
CEOMr. Daniel S. Goldberger
Websitehttps://www.electrocore.com/
Related Instruments
+0.88%
-3.80%
-1.04%
+0.76%
-1.09%
+0.38%
+0.23%
-1.84%
+0.19%
-1.21%
-1.12%
-0.08%
+0.25%
+0.92%
+0.54%
+0.90%
+5.82%
-3.77%
+0.10%
+0.49%
